tiprankstipranks
Universal Health Realty (UHT)
NYSE:UHT
Want to see UHT full AI Analyst Report?

Universal Health Realty Income (UHT) AI Stock Analysis

214 Followers

Top Page

UHT

Universal Health Realty Income

(NYSE:UHT)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
$42.00
▼(-4.18% Downside)
Action:Reiterated
Date:08/18/26
The score is primarily supported by stable operations and cash generation, but is held back by higher leverage, margin compression, and recent free-cash-flow contraction. Technical indicators also show weak momentum with the stock trading below key moving averages, while valuation is mixed (high yield offset by a high P/E).
Positive Factors
Recurring healthcare rental income
Long-term healthcare leases provide recurring property-level cash flows and reduce reliance on transaction-driven income. Exposure to hospitals, behavioral facilities, and medical offices also aligns the portfolio with ongoing healthcare demand.
Negative Factors
Elevated leverage
Higher leverage and a declining equity base reduce financial flexibility for a rate-sensitive REIT. Greater debt exposure can increase refinancing and interest costs, constrain acquisitions, and make cash flows more vulnerable to financing conditions.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring healthcare rental income
Long-term healthcare leases provide recurring property-level cash flows and reduce reliance on transaction-driven income. Exposure to hospitals, behavioral facilities, and medical offices also aligns the portfolio with ongoing healthcare demand.
Read all positive factors

Universal Health Realty Income (UHT) vs. SPDR S&P 500 ETF (SPY)

Universal Health Realty Income Business Overview & Revenue Model

Company Description
Universal Health Realty Income Trust (UHT) operates as a real estate investment trust (REIT) dedicated to investing in properties within the healthcare and human services industries. Its portfolio is diverse, encompassing a range of facilities suc...
How the Company Makes Money
UHT makes money primarily by owning healthcare real estate and generating recurring rental income under long-term lease agreements with healthcare operators. Its core revenue stream is lease payments from tenants (generally structured as fixed bas...

Universal Health Realty Income Financial Statement Overview

Summary
Steady revenue growth and consistently positive operating cash flow support fundamentals, but margin compression and a materially higher debt-to-equity (~2.75x TTM vs ~1.45x in 2021) reduce financial flexibility. Recent sharp negative free cash flow growth is an added watch item for dividend coverage and funding.
Income Statement
72
Positive
Balance Sheet
58
Neutral
Cash Flow
64
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue148.79M99.19M99.01M95.58M90.63M84.19M
Gross Profit113.22M93.59M93.53M90.25M85.53M79.78M
EBITDA65.21M67.58M70.49M65.16M58.41M145.45M
Net Income19.27M17.61M19.23M15.40M21.10M109.17M
Balance Sheet
Total Assets567.12M564.91M580.86M596.37M607.54M598.42M
Cash, Cash Equivalents and Short-Term Investments6.82M6.69M7.10M8.21M7.61M22.50M
Total Debt395.10M386.03M379.17M370.41M354.28M340.26M
Total Liabilities423.21M412.52M401.32M395.44M378.44M363.09M
Stockholders Equity143.91M152.38M179.54M200.93M229.10M235.33M
Cash Flow
Free Cash Flow48.25M49.09M46.91M43.47M33.19M34.74M
Operating Cash Flow48.25M49.09M46.91M43.47M46.80M47.73M
Investing Cash Flow-16.84M-14.96M-13.88M-19.87M-36.67M-24.43M
Financing Cash Flow-31.14M-34.55M-34.15M-23.01M-25.02M-6.54M

Universal Health Realty Income Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price43.83
Price Trends
50DMA
42.24
Negative
100DMA
41.28
Negative
200DMA
40.27
Positive
Market Momentum
MACD
-0.52
Positive
RSI
44.27
Neutral
STOCH
33.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UHT, the sentiment is Neutral. The current price of 43.83 is above the 20-day moving average (MA) of 42.18, above the 50-day MA of 42.24, and above the 200-day MA of 40.27, indicating a neutral trend. The MACD of -0.52 indicates Positive momentum. The RSI at 44.27 is Neutral, neither overbought nor oversold. The STOCH value of 33.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for UHT.

Universal Health Realty Income Risk Analysis

Universal Health Realty Income disclosed 33 risk factors in its most recent earnings report. Universal Health Realty Income reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Universal Health Realty Income Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$2.17B14.2812.28%5.41%59.94%49.34%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
65
Neutral
$426.08M22.154.96%10.14%5.66%
57
Neutral
$573.18M29.4612.79%6.80%0.75%7.29%
54
Neutral
$1.94B-7.24-16.22%0.43%-1.49%7.49%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UHT
Universal Health Realty Income
41.84
4.39
11.72%
LTC
LTC Properties
40.42
6.57
19.41%
DHC
Diversified Healthcare Trust
8.00
4.31
117.10%
CHCT
Community Healthcare
15.13
1.69
12.53%

Universal Health Realty Income Corporate Events

Executive/Board ChangesShareholder Meetings
Universal Health Realty Approves Executive Equity Awards, Governance Backed
Positive
Jun 11, 2026
On June 10, 2026, Universal Health Realty Income Trust’s board approved long-term incentive compensation in the form of restricted stock awards for its executive officers, with shares scheduled to vest on the second anniversary of the grant ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026